Conspectus
Over the past decade, we have contributed to
the chemistry of microbial
natural products and synthetic ligands, related to riboflavin and
uracils, that modulate immune cells called mucosal associated invariant
T cells (MAIT cells). These highly abundant T lymphocytes were only
discovered in 2003 and have become recognized for their importance
in mammalian immunology. Unlike other T cells, MAIT cells are not
activated by peptide or lipid antigens. In collaboration with immunology
and structural biology research groups, we discovered that they are
instead activated by unstable nitrogen-containing heterocycles synthesized
by bacteria. The most potent naturally occurring activating compound
(antigen) is 5-(2-oxopropylideneamino)-d-ribitylaminouracil (5-OP-RU). This compound is an imine (Schiff
base) formed through condensation between an intermediate in the biosynthesis
of riboflavin (vitamin B2) and a metabolic byproduct of mammalian
and microbial glycolysis. Although it is very unstable in water due
to intramolecular ring closure or hydrolysis, we were able to develop
a non-enzymatic synthesis that yields a pure kinetically stable compound
in a nonaqueous solvent. This compound has revolutionized the study
of MAIT cell immunology due to its potent activation (EC50 = 2 pM) of MAIT cells and its development into immunological reagents
for detecting and characterizing MAIT cells in tissues. MAIT cells
are now linked to key physiological processes and disease, including
antibacterial defense, tissue repair, regulation of graft-vs-host disease, gastritis, inflammatory bowel diseases,
and cancer. 5-OP-RU activates MAIT cells and, like a vaccine, has
been shown to protect mice from bacterial infections and cancers.
Mechanistic studies on the binding of 5-OP-RU to its dual protein
targets, the major histocompatibility complex class I related protein
(MR1) and the MAIT cell receptor (MAIT TCR), have involved synthetic
chemistry, 2D 1H NMR spectroscopy, mass spectrometry, computer
modeling and molecular dynamics simulations, biochemical, cellular,
and immunological assays, and protein structural biology. These combined
studies have revealed structural influences for 5-OP-RU in solution
on protein binding and antigen presentation and potency; informed
the development of potent (EC50 = 2 nM) and water stable
analogues; led to fluorescent analogues for detecting and tracking
binding proteins in and on cells; and enabled discovery of drugs and
drug-like molecules that bind MR1 and modulate MAIT cell function.
MAIT cells offer new opportunities for chemical synthesis to enhance
the stability, potency, selectivity, and bioavailability of small
molecule ligands for MR1 or MAIT TCR proteins, and to contribute to
the understanding of T cell immunity and the development of prospective
new immunomodulating medicines.